We have developed this website to support you in the luteal phase of your fertility journey. It provides additional information but does not replace the patient information leaflet that came with your medicine. Please consult the patient information leaflet for full guidance.

Here you will find information on:

Please always take Utrogestan Vaginal exactly as your doctor has advised you to and read the package leaflet that comes with your medicine before using it. Adverse events listed below.

Why have you been prescribed this medicine?

UTROGESTAN VAGINAL

 

As part of your assisted fertility treatment, the medication you take to control ovulation and the embryo transfer procedure can disrupt your body’s natural progesterone production. This can result in low levels of progesterone.

In the luteal phase (the part of your menstrual cycle after ovulation) progesterone is needed to thicken the uterus wall (called the endometrium), ready for an embryo to implant.

Utrogestan Vaginal contains progesterone and offers ‘luteal phase support’. When inserted into the vagina, progesterone helps increase the chances of successful implantation and pregnancy.

How to use

UTROGESTAN VAGINAL [click to play]

Always follow the instructions given to you by your doctor.

Before you start:

  • Please read the package leaflet that comes with your medicine before using it.
  • Practice good hygiene and wash your hands before and after inserting the capsule.

After you have inserted Utrogestan Vaginal

  • Wash your hands thoroughly after inserting the capsule.
  • Wearing a panty liner is recommended, as there may be some leakage from the dissolved capsule.

When not to use

UTROGESTAN VAGINAL

 

Always follow the instructions given to you by your doctor and read the package leaflet that comes with your medicine for a full list of warnings and precautions.

Do not use Utrogestan Vaginal if:

  • You are allergic (hypersensitive) to progesterone, soya lecithin, peanut, soya, or to any of the other ingredients of this medicine
  • You have severe liver disease
  • You have unexplained vaginal bleeding
  • You have mammary or genital tract carcinoma
  • You have thrombophlebitis
  • You have or have had blood clots in a vein (thrombosis), such as in the legs (deep venous thrombosis) or the lungs (pulmonary embolism)
  • You have cerebral haemorrhage
  • You have a rare blood problem called “porphyria” which is passed down in families (inherited)
  • You have had a missed abortion
  • You have had premature rupture of membranes (PPROM) (Utrogestan Vaginal 200mg ONLY).

Ref: Utrogestan Vaginal 200mg, Utrogestan Vaginal 300mg Patient information leaflet (PIL)

Precaution

Utrogestan Vaginal must only be administrated by the vaginal route. A complete medical examination must be performed before starting the treatment and regularly during the treatment. Utrogestan vaginal capsules are not suitable as a contraceptive. In rare cases, the use of micronised progesterone during the second and third trimester of pregnancy may lead to the development of gravidic cholestasis or hepatocellular liver disease.

Utrogestan Vaginal contains soya lecithin. As there is a possible relationship between allergy to soya and allergy to nuts, patients with nut allergy should avoid using Utrogestan vaginal capsules.

Adverse events as listed in the Utrogestan 200mg and 300mg PIL: Local intolerance (burning, itching or oily discharge) has been observed in clinical studies and has been reported in publications, but the incidence is extremely rare.

Applicable to Utrogestan Vaginal 300mg only: Serious allergic reaction which causes difficulty in breathing or dizziness. (frequency: very rare)

Patient Resources

Please read the package leaflet that comes with your medicine before using Utrogestan Vaginal.
Always use this medicine exactly as your healthcare professional has told you. If you are not sure, you can check with your doctor, pharmacist or nurse.

Ref: Utrogestan Vaginal Package Leaflet 200mg, Utrogestan Vaginal Package Leaflet 300mg

Reporting side effects

If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet.

You can also report side effects directly via the Yellow Card Scheme at www.mhra.gov.uk/yellowcard or search MHRA Yellow Card in the Google Play or Apple App Store. By reporting side effects you can help provide more information on the safety of this medicine.

References:

1. Besins Healthcare (UK) Ltd Utrogestan Vaginal 200mg Package Leaflet. Available from https://www.medicines.org.uk/emc/files/pil.3244.pdf Last accessed: October 2025.
2. Besins Healthcare (UK) Lts Utrogestan Vaginal 300mg Package Leaflet. Available from: https://www.medicines.org.uk/emc/product/15913/pil Last accessed: October 2025.
3. Utrogestan Vaginal 200mg Summary of Product Characteristics. Available from: https://www.medicines.org.uk/emc/product/3244/smpc Last accessed: October 2025.
4. Utrogestan Vaginal 300mg Summary of Product Characteristics. Available from: https://www.medicines.org.uk/emc/product/15913/smpc Last accessed: October 2025.